The Venture Codex Logo

The Venture Codex

Overview

Middle market private equity firm focused on healthcare and industrial sect

Founded

1988

Deals · 12mo

0

Stage focus

—

Geographic focus

United States

Sector focus

Finance
Financial Services
Health Care
Venture Capital

Investment portfolio

4rounds
NAMEDATESIZE
Genezen
Nov 2023Led
$19 MOther Equity
Vernal Biosciences
Jun 2023Led
$20 MOther Equity
Vernal Biosciences
Jun 2022Led
$21 MOther Equity
Arranta Bio
Oct 2019Led
$82 MOther Equity
Genezen
Nov 2023Led
$19 MOther Equity
Vernal Biosciences
Jun 2023Led
$20 MOther Equity
Vernal Biosciences
Jun 2022Led
$21 MOther Equity
Arranta Bio
Oct 2019Led
$82 MOther Equity
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Ampersand Capital Partners: 4 funding rounds are recorded in the selected participation categories.All available history.
Ampersand Capital Partners: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity40

Monthly Deal Activity

Ampersand Capital Partners: 4 deals are recorded across 85 months.All available history.
Ampersand Capital Partners: 4 deals are recorded across 85 months. All available history
MonthDeals
Oct '191
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '221
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '231
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Ampersand Capital Partners: Health & Life Sciences is the largest displayed sector by deal count (4 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Ampersand Capital Partners: Health & Life Sciences is the largest displayed sector by deal count (4 deals). All available history
SectorDeals
Health & Life Sciences4
Manufacturing1

Deal Size Distribution

Ampersand Capital Partners: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Ampersand Capital Partners: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M3
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Ampersand Capital Partners: United States has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Ampersand Capital Partners: United States has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
United States4
Ampersand Capital Partners: 6 co-investors are shown, with Charles River Laboratories sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Ampersand Capital Partners: 6 co-investors are shown, with Charles River Laboratories sharing 2 recorded deals. All available history
Co-investorShared deals
Charles River Laboratories2
Dynamk Capital2
Alloy Therapeutics1
ATUM1
Thermo Fisher Scientific1
Vermont Center for Emerging Technologies1

Investment Strategy

Ampersand Capital Partners: Led accounts for 100% and participating for 0% of round participation.All available history.
Ampersand Capital Partners: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led4100%
Participating00%
Ampersand Capital Partners: Single-lead accounts for 50% and co-led for 50% of lead dynamics.All available history.
Ampersand Capital Partners: Single-lead accounts for 50% and co-led for 50% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead250%
Co-led250%

Team

David J. Parker

General Partner

David Q. Anderson

General Partner

Julie F. Giles

Senior Accountant

Laurence McCarthy

Venture Partner

Patrick Walsh

Operating Partner

Richard A. Charpie

Founder and Managing Partner

Stuart Auerbach

Senior Advisor